Cytophage Technologies Ltd

CYTO.CA

$0.18

Closing

▲8.00%

1D

YTD

CYTO

BBG014Z5C0W1

Market cap

$10.75M

52 week high

$0.56

52 week low

$0.18

Volume

8,565

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$10.75M

Analysts' Rating

-

Price Target (Mean)

0

Total Analysts

0

P/E

Operating Margin

0%

Beta

Revenue Growth

0%

52 week high

$0.56

52 week low

$0.18

Div. Yield

%

EPS Growth

0

Company Profile

Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria, the Company generates customized phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a phage-display methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is poultry health products offered by the Company.